Point72 Hong Kong Ltd bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 91,477 shares of the company's stock, valued at approximately $3,627,000. Point72 Hong Kong Ltd owned approximately 0.10% of Acadia Healthcare as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Lindbrook Capital LLC raised its stake in Acadia Healthcare by 1,342.0% in the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock valued at $29,000 after buying an additional 671 shares during the period. Blue Trust Inc. raised its stake in Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after buying an additional 345 shares during the period. Nisa Investment Advisors LLC raised its stake in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after buying an additional 301 shares during the period. Signaturefd LLC raised its stake in Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after buying an additional 1,004 shares during the period. Finally, Quadrant Capital Group LLC raised its stake in Acadia Healthcare by 287.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after buying an additional 933 shares during the period.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on ACHC shares. Barclays decreased their target price on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 14th. Guggenheim started coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price on the stock. KeyCorp decreased their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Bank of America reduced their price target on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Finally, Royal Bank of Canada reduced their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.
Read Our Latest Analysis on Acadia Healthcare
Acadia Healthcare Price Performance
NASDAQ:ACHC traded up $0.21 during trading hours on Tuesday, hitting $25.29. The company's stock had a trading volume of 488,246 shares, compared to its average volume of 1,703,504. The stock has a fifty day simple moving average of $26.12 and a 200-day simple moving average of $35.37. The company has a market capitalization of $2.33 billion, a P/E ratio of 8.29, a PEG ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.05. The business had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare's revenue was up .3% compared to the same quarter last year. During the same period last year, the firm posted $0.84 earnings per share. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.
Acadia Healthcare Company Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
